InvestorsHub Logo

patientlywaiting

05/25/19 1:06 PM

#330473 RE: biopharm #330472

"So why do you think Stafford wanted to split off the IP at Peregrine?"

IP was shelved so whichever company picks up Avid on the cheap gets the rights to the IP. If you recall the the other company that licensed their IP to Oncologie not long ago reclaimed it. "IF" the IP actually has value as some here still believe it does, this could be one possible explanation.

"For why John Spring Stafford sold at $40 Xencor stock .... Maybe because he wanted to buy back at $30"

You just posted the following, what do you think?

Filing Date Name/Title Shares Transaction Value
05/02/19
Ronin Capital LLC
14,611 Acquisition at $29.87 per share 436,431
03/25/19
Ronin Capital LLC
3,500 Acquisition at $29.77 per share 104,195
03/22/19
Ronin Capital LLC
2,000 Acquisition at $29.96 per share 59,920
03/18/19
Ronin Capital LLC
1,100 Acquisition at $29.90 per share 32,890
03/15/19
Ronin Capital LLC
38,300 Acquisition at $29.02 per share 1,111,466

"The question now is INmunebio ties to Xencor and John Stafford"

I have reached the point where I believe that biotechs are one of the biggest SCAMS going to make wealthy criminals like Stafford a lot of money without any fear of any form of punishment other than having to pay a fine which requires paying back half the money you've stolen and you get to keep the rest and you get to do this over and over, again and again. It seems to me, just a little bit of science goes a long way, to making millions and millions of dollars for individuals like Stafford or Steven King for that matter, with only a FEW being made examples of for the fraud that goes on.

IMO


The Imp

05/25/19 2:10 PM

#330474 RE: biopharm #330472

Biopharm - do you still own CDMO?

patientlywaiting

05/26/19 12:04 PM

#330482 RE: biopharm #330472

"For why John Spring Stafford sold at $40 Xencor stock"

You should also add he sold $10M worth of stock. How about this. Here is an article dated JANUARY 21, 2019

"Have Insiders Been Selling Xencor, Inc. (NASDAQ:XNCR) Shares This Year?
Simply Wall St. January 21, 2019"

https://finance.yahoo.com/news/insiders-selling-xencor-inc-nasdaq-111200201.html

and now we have an article dated FEBRUARY 21, 2019

"FDA halts Xencor’s study of XmAb14045 following deaths"

https://www.pharmaceutical-technology.com/news/xencor-study-halted-xmab14045-acute-myeloid-leukaemia/

and next we have Johnny buying back all those shares cheaper in MARCH 2019 that you posted.

Even a blind man could figure this one out.

IMO